Nihon Kohden Corporation (TYO:6849)
Japan · Delayed Price · Currency is JPY | Market Cap | 232.92B -29.1% |
| Revenue (ttm) | 230.96B +3.0% |
| Net Income | 12.37B -28.2% |
| EPS | 75.78 -26.5% |
| Shares Out | 159.97M |
| PE Ratio | 19.21 |
| Forward PE | 18.91 |
| Dividend | 32.00 (2.21%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 502,500 |
| Average Volume | 514,260 |
| Open | 1,434.00 |
| Previous Close | 1,448.00 |
| Day's Range | 1,434.00 - 1,459.50 |
| 52-Week Range | 1,415.50 - 1,885.50 |
| Beta | 0.37 |
| RSI | 36.52 |
| Earnings Date | May 14, 2026 |
About Nihon Kohden
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside m... [Read more]
Financial Performance
In fiscal year 2025, Nihon Kohden's revenue was 225.42 billion, an increase of 1.55% compared to the previous year's 221.99 billion. Earnings were 14.10 billion, a decrease of -17.20%.
Financial StatementsNews
Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American Epilepsy Society (AES) 2025 Annual Meeting, hel...